Sarepta Therapeutics Inc (SRPT) — Net Asset Quality Index
Sarepta Therapeutics Inc (SRPT) has a Net Asset Quality Index of 47.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.19 Billion minus total liabilities of $1.66 Billion yields net assets of $1.53 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read SRPT liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sarepta Therapeutics Inc Net Asset Quality Index Over Time (1995–2025)
This chart shows how Sarepta Therapeutics Inc's Net Asset Quality Index has evolved across 31 annual periods from 1995 to 2025. As of June 2026, the index stands at 47.9%, representing net assets of $1.53 Billion against total assets of $3.19 Billion USD. For live market cap and overall valuation, see SRPT market cap.
Annual Net Asset Quality Index for Sarepta Therapeutics Inc (1995–2025)
The table below presents the year-by-year Net Asset Quality Index for Sarepta Therapeutics Inc from 1995 to 2025, covering 31 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Sarepta Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.1% | $1.14 Billion | $3.35 Billion | $2.21 Billion | ▼ -4.5 pp |
| 2024 | 38.5% | $1.53 Billion | $3.96 Billion | $2.44 Billion | ▲ +12.2 pp |
| 2023 | 26.3% | $859.34 Million | $3.26 Billion | $2.41 Billion | ▲ +14.0 pp |
| 2022 | 12.3% | $384.95 Million | $3.13 Billion | $2.74 Billion | ▼ -17.2 pp |
| 2021 | 29.5% | $928.01 Million | $3.15 Billion | $2.22 Billion | ▲ +4.0 pp |
| 2020 | 25.5% | $761.76 Million | $2.98 Billion | $2.22 Billion | ▼ -19.4 pp |
| 2019 | 44.9% | $818.19 Million | $1.82 Billion | $1.00 Billion | ▼ -18.0 pp |
| 2018 | 62.9% | $1.03 Billion | $1.64 Billion | $609.80 Million | ▲ +2.5 pp |
| 2017 | 60.3% | $789.22 Million | $1.31 Billion | $518.75 Million | ▼ -19.0 pp |
| 2016 | 79.4% | $336.69 Million | $424.10 Million | $87.41 Million | ▲ +9.9 pp |
| 2015 | 69.5% | $190.35 Million | $273.78 Million | $83.44 Million | ▼ -14.4 pp |
| 2014 | 83.9% | $247.65 Million | $295.03 Million | $47.38 Million | ▼ -0.8 pp |
| 2013 | 84.8% | $247.19 Million | $291.57 Million | $44.38 Million | ▲ +24.4 pp |
| 2012 | 60.3% | $123.68 Million | $204.99 Million | $81.31 Million | ▲ +3.3 pp |
| 2011 | 57.1% | $31.02 Million | $54.37 Million | $23.35 Million | ▲ +63.2 pp |
| 2010 | -6.1% | $-2.82 Million | $45.98 Million | $48.79 Million | ▼ -45.5 pp |
| 2009 | 39.4% | $23.63 Million | $60.03 Million | $36.40 Million | ▼ -22.2 pp |
| 2008 | 61.6% | $15.73 Million | $25.54 Million | $9.80 Million | ▼ -6.7 pp |
| 2007 | 68.3% | $26.38 Million | $38.64 Million | $12.26 Million | ▼ -24.0 pp |
| 2006 | 92.3% | $37.71 Million | $40.86 Million | $3.15 Million | ▼ -2.8 pp |
| 2005 | 95.1% | $53.66 Million | $56.41 Million | $2.75 Million | ▲ +3.0 pp |
| 2004 | 92.1% | $26.27 Million | $28.52 Million | $2.25 Million | ▲ +0.1 pp |
| 2003 | 92.0% | $43.39 Million | $47.15 Million | $3.75 Million | ▲ +10.0 pp |
| 2002 | 82.1% | $23.48 Million | $28.60 Million | $5.12 Million | ▼ -8.2 pp |
| 2001 | 90.3% | $30.53 Million | $33.82 Million | $3.28 Million | ▼ -4.8 pp |
| 2000 | 95.1% | $33.37 Million | $35.09 Million | $1.72 Million | ▲ +2.8 pp |
| 1999 | 92.2% | $11.90 Million | $12.90 Million | $1.00 Million | ▲ +4.0 pp |
| 1998 | 88.2% | $9.00 Million | $10.20 Million | $1.20 Million | ▼ -9.1 pp |
| 1997 | 97.3% | $18.30 Million | $18.80 Million | $500.00K | ▲ +78.3 pp |
| 1996 | 19.0% | $800.00K | $4.20 Million | $3.40 Million | ▼ -67.9 pp |
| 1995 | 87.0% | $2.00 Million | $2.30 Million | $300.00K | — |